Journal article
NCIC-CTG MA14 Trial: Tamoxifen (tam) vs. tam + octreotide (oct) for adjuvant treatment of stage I or II postmenopausal breast cancer
Authors
Pollak MN; Chapman JW; Pritchard KI; Krook JE; Dhaliwal HS; Vandenberg TA; Norris BD; Whelan TJ; Wilson CF; Shepherd LE
Journal
Journal of Clinical Oncology, Vol. 26, No. 15_suppl, pp. 532–532
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2008
DOI
10.1200/jco.2008.26.15_suppl.532
ISSN
0732-183X